Faculty of Medicine, Department of Basic Sciences, Assistant Prof. Caner Geyik's project titled "The Effect of KRAS Mutation and Nrf2 Inhibition on Irinotecan Treatment in Colorectal Cancer" has been accepted within the scope of TÜSEB Group A Emergency R&D Project Support Program.
